Results 261 to 270 of about 949,682 (362)

IPO9 Promotes Ovarian Cancer Progression by Suppressing HMOX1‐Dependent Ferroptosis

open access: yesHuman Mutation, Volume 2026, Issue 1, 2026.
Ovarian cancer (OC) poses a significant threat to women’s health, with current treatment strategies remaining suboptimal, necessitating the exploration of novel therapeutic targets and immune microenvironment dynamics. This study integrates multiomics data from TCGA, GEO, and IEU‐Open‐GWAS, employing scRNA‐seq, scPagwas, BayesPrism, and WGCNA to ...
Yimei Meng, Peiling Li, Sujit Nair
wiley   +1 more source

Systematic Analysis of Peripheral Immune Signatures and Diagnostic Model Construction in Patients With Uterine Fibroids

open access: yesJournal of Immunology Research, Volume 2026, Issue 1, 2026.
Objective To systematically characterize the peripheral immune signature of uterine fibroids (UFs) and to develop a diagnostic model for differentiating UF patients from healthy individuals, thereby providing new insights into UF immunopathogenesis.
Pei-Xian Li   +5 more
wiley   +1 more source

Primary fallopian tube carcinoma

open access: yesTaiwanese Journal of Obstetrics and Gynecology, 2012
Huang, Ben-Shian   +3 more
openaire   +3 more sources

Fallopian tube hydatidiform mole

open access: yesJournal of Obstetrics and Gynaecology, 2003
A A W, Mohamed, S D, Sharma
openaire   +2 more sources

Diagnostic Laparoscopy for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancers: A Retrospective Study

open access: diamond
Jongmyung Park   +5 more
openalex   +1 more source

Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study

open access: green, 2018
William P. Tew   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy